Biotech 2003 Life Sciences: Revaluation and Restructuring

Recognized as Biotech's investment visionary by Scientific American, G. Steven Burrill has authored this informative and respected report that provides an overview of the latest developments and trends in the biotech and life sciences sectors. This valuable resource is a "must have" for professionals working in and around these industries. As a member of the financial or capital markets, or in commercial operations, business development, investor relations, or a congressional staff member, take the time to learn the facts and data that prepare you for the future. Biotech 2003 delivers the latest data on the state of the biotech and the life sciences industries. Arm yourself with this essential 400 page resource. Get the facts behind the news in: Pharmaceuticals Diagnostics Nutraceuticals Agricultural Biotech Finance and Capital Markets Mergers and Acquisitions Regulatory Agencies Biodefense Review qualitative and quantitative analyses of key activities and industry highlights and the prospects for what lies ahead, including: Technology, product and company developments advancements and setbacks Legislative bills, regulatory strategies, political agendas, and industry reaction to geopolitical events Partnering and M&A agreements in the volatile financial market 400 pages of analyses, charts and grafts give the reader a concise and understandable reference to and background on these exciting sectors.